30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Envoy Medical Inc (COCH)

Track

The most recent insider trading activity occurred on February 12, 2026, with multiple significant buy transactions totaling over $8.6 million. Insiders, including the CEO and Interim CFO, acquired a substantial number of shares, indicating strong internal confidence. Prior to this, transactions were less frequent and of smaller value.
Stock chart
Ticker: COCH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Patel Mona Chetan
1 purchase — total 125,000 USD
Buy 12 Feb 2026
Value US$4,873,046.31 | Price 77.28 | Shares 19,396
Buy 12 Feb 2026
Value US$3,853,736.73 | Price 176.45 | Shares 88,232
Buy 12 Feb 2026
Value US$85,000.00 | Price 0.40 | Shares 212,500
Buy 12 Feb 2026
Value US$38,460.00 | Price 0.40 | Shares 96,150
Buy 12 Feb 2026
Value US$25,000.00 | Price 0.40 | Shares 62,500
Buy 12 Feb 2026
Value US$7,500,000.00 | Price 0.40 | Shares 18,750,000
Buy 11 Jun 2025
Value US$3,675.00 | Price 1.47 | Shares 2,500
Buy 6 Jun 2025
Value US$14,600.00 | Price 1.46 | Shares 10,000
Buy 27 May 2025
Value US$57,673.00 | Price 1.65 | Shares 35,000
Buy 23 May 2025
Value US$21,362.90 | Price 1.64 | Shares 13,000
Buy 22 May 2025
Value US$3,366.80 | Price 1.68 | Shares 2,000
Buy 20 Nov 2024
Value US$5,698.75 | Price 2.28 | Shares 2,500
Buy 11 Sep 2024
Value US$13,320.00 | Price 3.33 | Shares 4,000
Buy 9 Sep 2024
Value US$3,200.00 | Price 3.20 | Shares 1,000
Buy 21 Nov 2023
Value US$2,189.60 | Price 0.92 | Shares 2,380
Buy 21 Nov 2023
Value US$9,800.00 | Price 0.98 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-17 2026-02-12 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
19,396 -17.7%
77.28
US$4,873,046 		19,396 -17.7% 77.28 US$4,873,046
2026-02-17 2026-02-12 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
88,232 +22.2%
176.45
US$3,853,737 		88,232 +22.2% 176.45 US$3,853,737
2026-02-17 2026-02-12 B Purchase
Potashnick Robert

Interim CFO

Officer
46,399 +3.1%
136.87
US$3,081,767 		46,399 +3.1% 136.87 US$3,081,767
2026-02-17 2026-02-12 B Purchase
0.9
Kantor Susan
Non-Executive Director
96,150 +123.4%
0.40
US$38,460 		96,150 +123.4% 0.40 US$38,460
2026-02-17 2026-02-12 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
62,500 +26.6%
0.40
US$25,000 		62,500 +26.6% 0.40 US$25,000
2026-02-17 2026-02-12 B Purchase
TAYLOR GLEN A
Large shareholder
18,750,000 +634.8%
0.40
US$7,500,000 		18,750,000 +634.8% 0.40 US$7,500,000
2025-06-13 2025-06-11 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
2,500 +14.3%
1.47
US$3,675 		2,500 +14.3% 1.47 US$3,675
2025-06-10 2025-06-06 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
10,000 +133.3%
1.46
US$14,600 		10,000 +133.3% 1.46 US$14,600
2025-05-27 2025-05-27 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
35,000 +233.3%
1.65
US$57,673 		35,000 +233.3% 1.65 US$57,673
2025-05-27 2025-05-23 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
13,000 +650.0%
1.64
US$21,363 		13,000 +650.0% 1.64 US$21,363
2025-05-27 2025-05-22 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
2,000 +inf%
1.68
US$3,367 		2,000 +inf% 1.68 US$3,367
2024-11-22 2024-11-20 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
2,500 +50.0%
2.28
US$5,699 		2,500 +50.0% 2.28 US$5,699
2024-09-11 2024-09-11 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
4,000 +400.0%
3.33
US$13,320 		4,000 +400.0% 3.33 US$13,320
2024-09-11 2024-09-09 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
1,000 +inf%
3.20
US$3,200 		1,000 +inf% 3.20 US$3,200
2023-11-24 2023-11-21 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
2,380 +2.0%
0.92
US$2,190 		2,380 +2.0% 0.92 US$2,190
2023-11-24 2023-11-21 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
10,000 +9.2%
0.98
US$9,800 		10,000 +9.2% 0.98 US$9,800
Explore more

More insider trading research around Envoy Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America